Included in the formulation
АТХ:S.02.D.A.30 Combined preparations
S.02.D.A Analgesics and anesthetics
Pharmacodynamics:Combination drug for topical application in otolaryngology.
Lidocaine has an analgesic effect when applied topically.
Phenazone has a pronounced anti-inflammatory effect, reduces the onset of anesthetic effect of lidocaine, increases its severity and duration.
Pharmacokinetics:After instillation in the ear, the anesthetic effect begins in 5 minutes and reaches a maximum after 15-30 minutes.
After instillation components of the drug do not enter the bloodstream and do not have a systemic effect.
Indications:It is used for local symptomatic treatment and pain relief for acute otitis media, otitis due to barotrauma and otitis in case of influenza.
VIII.H65-H75.H66 Purulent and unspecified otitis media
Contraindications:Perforation of the tympanic membrane due to trauma or infection, individual intolerance.
Carefully:Hypersensitivity.
Pregnancy and lactation:Recommendations for FDA - Category B. It is used during pregnancy and lactation.
Dosing and Administration:By 4 drops in the external auditory meatus 2-3 times a day. The duration of the course of treatment is not more than 10 days.
Side effects:Irritation and congestion of the auditory canal, allergic reactions.
Overdose:Cases of overdose are not described.
Treatment is symptomatic.
Interaction:Clinically significant interactions are not described.
Special instructions:Possible use in infants.
After opening the vial the drug is suitable for re-use.